DPP-4 inhibitor and sulfonylurea

This page covers all DPP-4 inhibitor and sulfonylurea drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting DPP-4.

Targets

DPP-4

Phase 2 pipeline (1)

• Alogliptin and glimepiride · Takeda · Diabetes
  Alogliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, and glimepiride is a sulfonylurea that stimulates insulin release.